Stories & News

LRA-Funded Research Aims at Preventing Heart Disease in Kids With Lupus

February 14, 2022 Being a kid isn't always easy, but growing up with lupus makes it a much harder challenge....

LRA-Funded Research Found a Connection Between the Epstein-Barr Virus Infection and MS as an Autoimmune Disease

February 4, 2022 A potential new cause of the autoimmune disease multiple sclerosis (MS) was discovered by researchers partly funded...

Baricitinib Development as a Lupus Treatment Discontinued

January 28, 2022 The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...

LRA-Funded Research Uncovers a Novel Pathway for Lupus Nephritis

January 28, 2022 The investigators from The Accelerated Medicines Partnership® Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP® RA/SLE) Program, in...

Shingles Vaccine Recommended for Immunocompromised People

January, 2022 As of January, 2022, the U.S. Centers for Disease Control and Prevention (CDC) recommends the use of the...

FDA Authorizes Evusheld Emergency Use to Prevent COVID-19 in Immunocompromised Patients

December 9, 2021 People with lupus can be immunocompromised because of the disease itself or medications that suppress the immune...

Aurinia Announces Positive Long-Term Results on Lupykinis™ for Lupus Nephritis

December 9, 2021 The LRA is pleased to share positive topline three-year efficacy and safety results reported today by Aurinia...

LRA Partnering with NIH, FNIH and Others on Groundbreaking Initiative

December 9, 2021 The Lupus Research Alliance (LRA) is proud and excited to partner again with the National Institutes of...

Thanks To NY JETS for Hosting LUPUS AWARENESS DAY November 21

November 22, 2021 The New York Jets and Lupus Research Alliance (LRA) hosted Lupus Awareness Day on November 21, 2021,...

2021 Breaking Through Gala

This year the Lupus Research Alliance Breaking Through Gala will take place the evening of Monday, November 22, 2021...

Pivotal LRA-Funded Research Shared at Annual Rheumatology Meeting

November 15, 2021 The Lupus Research Alliance (LRA) supports research into causes and mechanisms of lupus, and identification of targets...

Promise of Additional Lupus Therapies Highlighted at ACR 2021 Annual Meeting

November 9, 2021 Results of clinical trials testing many existing and potential lupus treatments were highlighted at the American College...